To address this question, we analyzed the expression of hypoxia marker gene CA9 by immunohistochemistry (IHC) in two independent tissue microarrays (TMAs) with 38 and 78 prostate tumor and benign tissue samples, respectively. Here, CA9 is linked to prostate neoplasm.